Outcomes4Me, the developer of the leading direct-to-patient, AI-driven platform transforming the cancer care experience, announced the close of a $21M funding round.
"AI will reshape cancer...
Roche announced the launch of the first clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay,...
Evolent Health, Inc., a $2 billion revenue company focused on achieving better health outcomes for people with complex conditions, announced it is partnering with Careology, a...
The US Oncology Network , the largest organization of its kind dedicated to advancing local cancer care and better patient outcomes, announced that Regional...
AtlantiCare is the first healthcare system in the northeastern U.S. to use Optellum's Virtual Nodule Clinic. Located in New Jersey, it is integrating the innovative technology into...
